TH

Todd M. Heidelbaugh

AB AbbVie: 59 patents #22 of 1,308Top 2%
Overall (All Time): #40,646 of 4,157,543Top 1%
59
Patents All Time

Issued Patents All Time

Showing 25 most recent of 59 patents

Patent #TitleCo-InventorsDate
9849113 Methods of treating α adrenergic mediated conditions Daniel W. Gil, John E. Donello, Wenkui K. Fang, Phong X. Nguyen, Ken Chow +3 more 2017-12-26
9623006 Methods of treating α adrenergic mediated conditions Daniel W. Gil, John E. Donello, Wenkui K. Fang, Phong X. Nguyen, Ken Chow +3 more 2017-04-18
9572792 Coumarin compounds as receptor modulators with therapeutic utility John R. Cappiello, Phong X. Nguyen, Dario G. Gomez 2017-02-21
9073888 Coumarin compounds as receptor modulators with therapeutic utility John R. Cappiello, Phong X. Nguyen, Dario G. Gomez 2015-07-07
9034910 Methods of treating alpha adrenergic mediated conditions Daniel W. Gil, John E. Donello, Wenkui K. Fang, Phong X. Nguyen, Ken Chow +3 more 2015-05-19
8828973 Compounds as receptor modulators with therapeutic utility Phong X. Nguyen, John R. Cappiello 2014-09-09
8815923 Therapeutic compounds Santosh C. Sinha, Smita S. Bhat, Daniel W. Gil, Ken Chow, Michael E. Garst 2014-08-26
8809379 Selective subtype alpha 2 adrenergic agents and methods for use thereof Ken Chow, Santosh C. Sinha, Phong X. Nguyen, Ling Li, Wenkui K. Fang +2 more 2014-08-19
8741875 Compounds as receptor modulators with therapeutic utility Phong X. Nguyen, John R. Cappiello 2014-06-03
8735438 Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors Santosh C. Sinha, Smita S. Bhat, Ken Chow, Michael E. Garst 2014-05-27
8735399 Selective subtype alpha 2 adrenergic agents and methods for use thereof Ken Chow, Santosh C. Sinha, Phong X. Nguyen, Wenkui K. Fang, Ling Li +2 more 2014-05-27
8703745 Compounds as receptor modulators with therapeutic utility Phong X. Nguyen 2014-04-22
8703746 Compounds as receptor modulators with therapeutic utility Phong X. Nguyen 2014-04-22
8653270 Compounds as receptor modulators with therapeutic utility Phong X. Nguyen 2014-02-18
8653062 Compounds as receptor modulators with therapeutic utility Phong X. Nguyen 2014-02-18
8486969 Therapeutic compounds Santosh C. Sinha, Smita S. Bhat, Daniel W. Gil, Ken Chow, Michael E. Garst 2013-07-16
8486985 Selective subtype alpha 2 adrenergic agents and methods for use thereof Phong X. Nguyen, Ken Chow 2013-07-16
8440644 Compounds as receptor modulators with therapeutic utility Phong X. Nguyen 2013-05-14
8426454 Therapeutic compounds Santosh C. Sinha, Smita S. Bhat, Daniel W. Gil, Ken Chow, Michael E. Garst 2013-04-23
8383646 Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compounds Santosh C. Sinha, Ken Chow, Smita S. Bhat, Phong X. Nguyen, Michael E. Garst 2013-02-26
8362022 Selective subtype alpha 2 adrenergic agents and methods for use thereof Ken Chow, Santosh C. Sinha, Phong X. Nguyen, Wenkui K. Fang, Ling Li +2 more 2013-01-29
8329918 Selective alpha 2B/2C agonists Phong X. Nguyen, Ken Chow, Dario G. Gomez, Wenkui K. Fang, Santosh C. Sinha +2 more 2012-12-11
8258167 Naphthylmethylimidizoles as therapeutic agents Phong X. Nguyen, Ken Chow, Michael E. Garst 2012-09-04
8227499 Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors Santosh C. Sinha, Smita S. Bhat, Ken Chow 2012-07-24
8183414 N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as subtype selective modulators of ALPHA2B or ALPHA2B and ALPHA2C adrenoceptors Ken Chow, Janet A. Takeuchi, Ling Li, Phong X. Nguyen, Evelyn G. Corpuz +3 more 2012-05-22